What is Spexib HCG 150mg (PALBOCICLIB)?
CDK4/6 inhibitor for hormone receptor-positive, HER2-negative advanced/metastatic breast cancer — combined with letrozole or fulvestrant as standard first and second-line treatment.
How it Works
Inhibits cyclin-dependent kinases 4 and 6 (CDK4/6) — prevents Rb phosphorylation and cell cycle progression from G1 to S phase, halting tumor proliferation.
Quick Specs
| Form | Oral tablets — pre-dosed |
| Shelf Life | 2–3 years (properly stored) |
| Storage | Room temperature (15–25°C), cool dry place |
| Brand | Pharma |
| Pack Size | 10×10 (100 tablets) |
| Dose per Tablet | 150MG |
Frequently Asked Questions
🧪 Peptide Research Tools: Use QSC's free peptide calculators — reconstitution, BAC water, dosing, half-life, and mixing charts.
🌍 Domestic shipping: 🇺🇸 USA 5–7 days
🌏 International shipping: 7–14 days